(Q54171000)
Statements
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. (English)
Stiff P
Bayer R
Camarda M
Tan S
Dolan J
Potkul R
Loutfi S
Kinch L
Sosman J
Peace D
1 June 1995
57
3
278-285